Bottom content

Curabitur sed urna id nunc pulvinar semper. Nunc sit amet tortor sit amet lacus sagittis posuere cursus vitae nunc.Etiam venenatis, turpis at eleifend porta, nisl nulla bibendum justo.

How we help you

Latest News / Events

Bladder Cancer: SMC Approve use of Avelumab (Bavencio) for use in Scotland 09/08/2021

Bladder Cancer: SMC Approve use of Avelumab (Bavencio) for use in Scotland Action Bladder Cancer UK are delighted that the Scottish Medicines Consortium have announced today that the immunotherapy Avelumab (Bavencio) has been accepted for use in Scotland. In a phase III study, ma...

News & Events
Read more

We're on Twitter

Facebook